Graham Wood
Plus aucun poste en cours
Profil
Graham Wood served as the President of CRS Management, Inc. from 2008 to 2011.
He then worked as the Chief Executive Officer of Manna Research, Inc. from 2012 to 2015.
After that, he was the Chief Research & Development Officer at Altasciences Co., Inc. from 2018 to 2019.
In 2019, he became the Chief Scientific Officer at Neptune Wellness Solutions, Inc. and in 2020, he served as the Chief Operating Officer at Tetra Bio-Pharma, Inc. Dr. Wood earned a doctorate degree from McGill University in 2002.
Anciens postes connus de Graham Wood
| Sociétés | Poste | Fin |
|---|---|---|
| TETRA BIO-PHARMA INC. | Directeur des opérations | 01/04/2021 |
| NEPTUNE WELLNESS SOLUTIONS INC. | Directeur Technique/Scientifique/R&D | 01/09/2020 |
Altasciences Co., Inc.
 Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | Directeur Technique/Scientifique/R&D | 01/04/2019 |
Manna Research, Inc.
 Manna Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of LMC Diabetes & Endocrinology Ltd., Manna Research, Inc. has over 20 years of experience providing research trials across almost every therapeutic area. The company is based in Montréal, Canada. Through clinical research, the Canadian company's work has improved health for tens of millions of people worldwide. The company offers research opportunities and resources for stress management, mindful eating, and grocery shopping. Additionally, they have expanded their services to include dermatology research. Manna Research was acquired by LMC Diabetes & Endocrinology Ltd. on March 12, 2015. | Directeur Général | 01/06/2015 |
CRS Management, Inc.
 CRS Management, Inc. Miscellaneous Commercial ServicesCommercial Services Cetero Research is an industry leading contract research organization (CRO) in early phase research services. With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies – more than any other CRO. Cetero’s proven track record allows the company to provide flexible and high quality drug development services, and its time-tested systems produce consistent and reliable data Cetero’s clients can trust. Cetero’s clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Its bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules. In addition, Cetero owns and operates a full-scale central laboratory supporting Phase I-IV clinical trials in North and South America. | President | 01/11/2011 |
Formation de Graham Wood
| McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEPTUNE WELLNESS SOLUTIONS INC. | Health Technology |
| TETRA BIO-PHARMA INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CRS Management, Inc.
CRS Management, Inc. Miscellaneous Commercial ServicesCommercial Services Cetero Research is an industry leading contract research organization (CRO) in early phase research services. With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies – more than any other CRO. Cetero’s proven track record allows the company to provide flexible and high quality drug development services, and its time-tested systems produce consistent and reliable data Cetero’s clients can trust. Cetero’s clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Its bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules. In addition, Cetero owns and operates a full-scale central laboratory supporting Phase I-IV clinical trials in North and South America. | Commercial Services |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | Commercial Services |
Manna Research, Inc.
Manna Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of LMC Diabetes & Endocrinology Ltd., Manna Research, Inc. has over 20 years of experience providing research trials across almost every therapeutic area. The company is based in Montréal, Canada. Through clinical research, the Canadian company's work has improved health for tens of millions of people worldwide. The company offers research opportunities and resources for stress management, mindful eating, and grocery shopping. Additionally, they have expanded their services to include dermatology research. Manna Research was acquired by LMC Diabetes & Endocrinology Ltd. on March 12, 2015. | Commercial Services |